We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Oral Clofarabine in Intermediate to High Risk Myelodysplastic Patients

This study has been terminated.
(Drug provider withdrew support)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01003678
First Posted: October 29, 2009
Last Update Posted: June 3, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Roswell Park Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)